Galectin-3 and the Key to Relieving COVID-19 Symptoms

New treatments using naturally occurring modified fruit pectin and targeted drugs offer hope of taming galectin-3.
Galectin-3 and the Key to Relieving COVID-19 Symptoms
(Andrii Vodolazhskyi/Shutterstock)
Vance Voetberg
10/21/2023
Updated:
10/21/2023
0:00

Since the first wave of COVID-19 in 2020, researchers have raced to unravel the virus’ mysteries. One surprising discovery points to galectin-3, a usually benign protein our bodies produce, as an accomplice in exacerbating and prolonging the disease’s symptoms.

Galectin-3 fuels out-of-control inflammation, enabling the virus to evade the body’s defenses.

Scientists have struggled to rein in this rogue protein. But new treatments using naturally occurring modified fruit pectin and targeted drugs offer hope of taming galectin-3 and providing relief for COVID-19 patients.

What Is Galectin-3 and Why Does It Matter?

First discovered in 1971, galectin-3 is a protein that regulates inflammation and binds to pathogens. It helps the body’s immune system respond to threats. However, galectin-3 often overreacts, causing excessive inflammation, especially in diseases like cancer, heart disease, and autoimmune disorders.

Researchers don’t fully understand why galectin-3 spikes when the body is under attack. But they see its overabundance as an immune dysfunction marker that prolongs illness.

“The constant increase in the number of papers published in the most recent years and concerning the role of this protein in many clinical conditions and diseases testify the great clinical relevance of [galectin-3] in human pathophysiology,” authors of a 2018 research paper published in the International Journal of Molecular Sciences wrote.
Galectin-3 drives relentless inflammation through its many binding partners, Tariq Sethi, a respiratory scientist with over 30 years of experience in the field of immunology and inflammation, told The Epoch Times. In chronic unresolved inflammation, such as the cytokine storm in COVID-19, galectin-3 triggers runaway production of itself, fueling more robust inflammatory responses, he noted.

Inhibiting Galectin-3 May Help Against COVID-19

Researchers theorized that galectin-3 levels rise with COVID-19 onset, prompting a study to explore its potential as a disease severity marker. In the 2023 Scientific Reports publication, 280 patients were categorized by severity—into mild, moderate, severe, and critical groups. As expected, critical patients exhibited markedly elevated galectin-3 and other inflammatory cells compared to milder cases.

“Studies have shown that depending on the stage of COVID-19 infection in patients, cytokine inhibition is one of the most effective therapeutic methods,” Frederick Odun-Ayo, who holds a doctorate in biotechnology and is a biochemist researching galectin-3, told The Epoch Times.

Cytokines are vital proteins that regulate the growth and functions of the immune system and blood cells. Galectin-3 spurs cytokines, which can cause excessive damage as a result of fighting COVID-19, Mr. Odun-Ayo said. Regulating cytokines through galectin-3 inhibition should be a priority, he noted.

Another 2023 study published in the American Journal of Respiratory and Critical Care Medicine showed galectin-3 inhibitors reduced the protein’s levels in COVID-19 patients, decreasing inflammation, coagulation, and fibrosis. But the study was small, including only 41 patients with mild COVID-19 symptoms. There were no patients who experienced severe complications.
A third 2023 study, a randomized controlled trial published in the online journal Vaccines, demonstrated a galectin-3 inhibitor reduced COVID-19 viral load and enabled rapid viral clearance. It prevented virus cell entry. Researchers concluded that given their efficacy and tolerability, galectin-3 inhibitors may treat and prevent COVID-19.

Ways to Reduce Galectin-3 Levels

Though critical, galectin-3’s overproduction perpetuates disease—from COVID-19 to cancer. One study published in the Journal of Traditional and Complementary Medicine found meditation and music reduced galectin-3 in patients who had previously experienced a heart attack.
Modified citrus pectin—a natural dietary fiber—shows promise against galectin-3 overyielding. One study demonstrated it suppressed cancerous tumor growth. Another revealed it reduced severity in kidney patients by binding and disarming galectin-3.
However, there are currently no clinical studies that prove pectin’s effectiveness against COVID-19 specifically. Some contend it could improve outcomes by lowering galectin-3.

While some factors like age cannot be altered, unhealthy lifestyle factors like poor diet, stress, and poor sleep habits adversely impact galectin-3 levels linked to cardiovascular and fibrotic diseases, according to Mr. Odun-Ayo. Increasing dietary fiber intake helps reduce the risk of developing diseases caused by galectin-3. Keeping healthy lifestyle habits helps restore balance to the body’s internal inflammatory response and reduce chronic inflammation that damages health, he added.

Vance Voetberg is a journalist for The Epoch Times based in the Pacific Northwest. He holds a B.S. in journalism and aims to present truthful, inspiring health-related news. He is the founder of the nutrition blog “Running On Butter.”
Related Topics